158 related articles for article (PubMed ID: 9252666)
1. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.
Engblom P; Rantanen V; Kulmala J; Grènman S
Anticancer Res; 1996; 16(4A):1743-7. PubMed ID: 8712694
[TBL] [Abstract][Full Text] [Related]
3. Endometrial cancer cell lines are sensitive to paclitaxel.
Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
[TBL] [Abstract][Full Text] [Related]
4. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Grènman S
Cancer; 1999 Nov; 86(10):2066-73. PubMed ID: 10570433
[TBL] [Abstract][Full Text] [Related]
6. Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines.
Engblom P; Rantanen V; Kulmala J; Helenius H; Grènman S
Br J Cancer; 1999 Jan; 79(2):286-92. PubMed ID: 9888470
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.
Marth C; Zeimet AG; Widschwendter M; Ludescher C; Kaern J; Tropé C; Gastl G; Daxenbichler G; Dapunt O
Cancer Res; 1997 Sep; 57(17):3818-22. PubMed ID: 9288793
[TBL] [Abstract][Full Text] [Related]
8. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1997; 17(2A):939-43. PubMed ID: 9137431
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
Kelland LR; Abel G
Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
Silvestrini R; Zaffaroni N; Orlandi L; Oriana S
Stem Cells; 1993 Nov; 11(6):528-35. PubMed ID: 7906583
[TBL] [Abstract][Full Text] [Related]
11. Electrochemical monitoring of anticancer compounds on the human ovarian carcinoma cell line A2780 and its adriamycin- and Cisplatin-resistant variants.
Woolley DE; Tetlow LC; Adlam DJ; Gearey D; Eden RD; Ward TH; Allen TD
Exp Cell Res; 2002 Feb; 273(1):65-72. PubMed ID: 11795947
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines.
Smith JA; Ngo H; Martin MC; Wolf JK
Gynecol Oncol; 2005 Jul; 98(1):141-5. PubMed ID: 15963813
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to taxoid derivatives of a newly established human endometrioid ovarian adenocarcinoma radioresistant cell line.
Griffon G; Merlin JL; Parache RM; Martinet N; Marchal S; Nabet F; Wellman M; Barlier C; Marchal C
Anticancer Res; 1996; 16(1):177-87. PubMed ID: 8615606
[TBL] [Abstract][Full Text] [Related]
15. Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel.
Britten RA; Klein K
Anticancer Drugs; 2000 Jul; 11(6):439-43. PubMed ID: 11001384
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
Ojima I; Slater JC; Michaud E; Kuduk SD; Bounaud PY; Vrignaud P; Bissery MC; Veith JM; Pera P; Bernacki RJ
J Med Chem; 1996 Sep; 39(20):3889-96. PubMed ID: 8831755
[TBL] [Abstract][Full Text] [Related]
17. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
[TBL] [Abstract][Full Text] [Related]
18. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
19. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
Hennequin C; Giocanti N; Favaudon V
Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species.
Lin HL; Liu TY; Chau GY; Lui WY; Chi CW
Cancer; 2000 Sep; 89(5):983-94. PubMed ID: 10964328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
